Us Bancorp \De\ Novavax Inc Transaction History

Us Bancorp \De\

$74.1 Billion
Q1 2025

A detailed history of Us Bancorp \De\ transactions in Novavax Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 12,051 shares of NVAX stock, worth $79,657. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,051

Previous 11,806 2.08%

Holding current value

$79,657

Previous $94,000 18.09%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	BUY	$6.41 - $10.82 $1,570 - $2,650	245 Added 2.08%	12,051 $77,000
Q4 2024 Feb 05, 2025	SELL	$7.22 - $14.68 $3,559 - $7,237	-493 Reduced 4.01%	11,806 $94,000
Q3 2024 Oct 28, 2024	BUY	$10.71 - $17.11 $128,102 - $204,652	11,961 Added 3538.76%	12,299 $155,000
Q2 2024 Aug 06, 2024	SELL	$3.89 - $20.97 $5,757 - $31,035	-1,480 Reduced 81.41%	338 $4,000
Q1 2024 May 07, 2024	BUY	$3.76 - $6.02 $2,342 - $3,750	623 Added 52.13%	1,818 $8,000
Q4 2023 Feb 09, 2024	SELL	$4.8 - $7.67 $22,684 - $36,248	-4,726 Reduced 79.82%	1,195 $5,000
Q3 2023 Nov 03, 2023	SELL	$6.81 - $9.74 $18,012 - $25,762	-2,645 Reduced 30.88%	5,921 $42,000
Q2 2023 Aug 09, 2023	BUY	$6.67 - $9.52 $24,185 - $34,519	3,626 Added 73.4%	8,566 $63,000
Q1 2023 May 09, 2023	BUY	$5.76 - $12.48 $15,868 - $34,382	2,755 Added 126.09%	4,940 $34,000
Q4 2022 Feb 13, 2023	SELL	$8.86 - $25.04 $4,155 - $11,743	-469 Reduced 17.67%	2,185 $22,000
Q3 2022 Oct 27, 2022	BUY	$18.2 - $76.12 $6,988 - $29,230	384 Added 16.92%	2,654 $49,000
Q2 2022 Aug 01, 2022	BUY	$36.28 - $75.29 $6,784 - $14,079	187 Added 8.98%	2,270 $117,000
Q1 2022 May 11, 2022	BUY	$69.73 - $142.9 $42,814 - $87,740	614 Added 41.8%	2,083 $154,000
Q4 2021 Feb 11, 2022	SELL	$134.56 - $217.97 $74,815 - $121,191	-556 Reduced 27.46%	1,469 $211,000
Q3 2021 Nov 10, 2021	SELL	$177.8 - $270.58 $16,535 - $25,163	-93 Reduced 4.39%	2,025 $419,000
Q2 2021 Aug 05, 2021	SELL	$121.0 - $257.67 $330,330 - $703,439	-2,730 Reduced 56.31%	2,118 $449,000
Q1 2021 Apr 28, 2021	SELL	$112.98 - $319.93 $209,916 - $594,429	-1,858 Reduced 27.71%	4,848 $879,000
Q4 2020 Feb 04, 2021	BUY	$78.74 - $139.5 $81,259 - $143,964	1,032 Added 18.19%	6,706 $748,000
Q3 2020 Nov 10, 2020	BUY	$79.44 - $178.51 $160,230 - $360,054	2,017 Added 55.15%	5,674 $615,000
Q2 2020 Aug 07, 2020	BUY	$13.86 - $83.61 $45,142 - $272,317	3,257 Added 814.25%	3,657 $305,000
Q1 2020 May 13, 2020	BUY	$3.93 - $16.0 $1,572 - $6,400	400 New	400 $5,000

Others Institutions Holding NVAX

# of Institutions

300

Shares Held

90M

Call Options Held

5.76M

Put Options Held

6.65M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $517M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account